|
Delayed
Xetra
11:36:00 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 10.53 EUR | +1.23% |
|
-2.12% | +51.20% |
| Current month | -5.35% | ||
| 1 month | +8.74% |
Main features
| IE00BM8R0N95 | Fees | 0.5% | Dividend Policy | Market Cap | |
|---|---|---|---|---|---|
| Currency | EUR | AuM (CAD) | 92.47M | Replication Method | Direct (Physical) |
| Number of securities | 49 | AuM evolution | - | Date of creation | 2021-11-03 |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | Developed markets |
| Theme and Sector | BioTech & Genomics |
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index (the Index).
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-14 | €10.53 | +1.23% | 32,940 |
| 26-10-13 | €10.41 | -2.62% | 34,476 |
| 26-10-12 | €10.69 | -1.11% | 30,941 |
| 26-10-09 | €10.81 | +4.41% | 30,990 |
| 26-10-08 | €10.35 | -3.83% | 62,112 |
- Stock Market
- ETF
- GN0M ETF
Select your edition
All financial news and data tailored to specific country editions




















